Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Cytek Announces Resignation of Chief Operating Officer Chris Williams
September 12, 2024 15:20 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris...
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
August 21, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.
Cytek Biosciences to Participate in Upcoming Investor Conferences
August 08, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences Reports Second Quarter 2024 Financial Results
August 06, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
July 30, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek has developed a revolutionary tool to automate panel design. SpectroPanel is an intelligent algorithm that suggests optimized panels in minutes.
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
July 30, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second...
Cytek Biosciences Announces $50 Million Stock Repurchase Program
June 06, 2024 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the...
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
May 30, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming...
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
May 28, 2024 17:30 ET
|
Cytek Biosciences, Inc.
Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use.